Paper Details

  1. Home
  2. Paper Details

Effectiveness of etravirine-based therapy for treatment-experienced HIV-infected patients.

Author: Banda-LaraMarco Issac, Chavez-GarcíaMarcelino, Cruz-HerreraJavier Enrique, Domínguez-HermosilloJuan Carlos, Gaytan-MartínezJesús Enrique, Huerta GarcíaGloria, Manjarrez-TellezBulmaro, Mata-MarínJosé Antonio, Nuñez-RodríguezNohemi, Sandoval-RamírezJorge Luis, Villagómez-RuizAlfredo

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study evaluated the effectiveness of efavirenz (ETV) plus an optimized background regimen in a cohort of highly treatment-experienced HIV-1 patients. ETV has shown significant clinical benefits in patients with antiretroviral resistance.
Paper Details　
Original Abstract of the Article :
Treatment options are limited for HIV-1-infected individuals who have received extensive previous antiretroviral therapy. ETV has shown significant clinical benefits in treatment-experienced HIV-1+ patients with antiretroviral resistance. The aim of this study was to evaluate the effectiveness of ET...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.3855/jidc.7512

データ提供：米国国立医学図書館（NLM）

Etravirine: A New Hope for Treatment-Experienced HIV Patients

The fight against HIV is an ongoing battle, like traversing a vast and treacherous desert. This study explores the effectiveness of etravirine-based therapy for treatment-experienced HIV-infected patients, a population facing significant challenges due to drug resistance.

A New Weapon in the Arsenal

The authors conducted a real-life study to assess the clinical benefits of etravirine in highly HIV-1 antiretroviral-experienced patients. The results indicate that etravirine, when combined with an optimized background regimen, can effectively suppress viral load and improve clinical outcomes in this challenging patient population. This finding offers new hope for individuals who have developed resistance to other antiretroviral therapies.

A Path to Long-Term Control

This research provides valuable insights into the use of etravirine in treatment-experienced HIV-infected patients, highlighting its potential to improve long-term viral control and enhance the quality of life for individuals living with this chronic condition. It's like discovering a new oasis of hope in the arid landscape of HIV treatment.

Dr.Camel's Conclusion

Etravirine, like a refreshing spring in the desert, offers a new and effective treatment option for HIV-infected patients who have developed resistance to other therapies. This discovery represents a significant advancement in the fight against HIV, providing a path toward long-term viral control and improved health outcomes for those living with this complex condition.

Date :
  1. Date Completed 2017-02-06
  2. Date Revised 2020-12-09
Further Info :

Pubmed ID

27367009

DOI: Digital Object Identifier

10.3855/jidc.7512

Related Literature

Article Analysis
・Side Effects of etravirine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.